TY  - BOOK
AU  - Nermine Shawki Kamal 
AU  - Emad Hamada , 
AU  - Hamdy Abdelazim , 
AU  - Wafaa Elmetenawy , 
TI  - Value of bone resorption markers to predict skeletal related events and response to bisphosphonate therapy in patients with bone metastases : : A prspective randomized study / 
PY  - 2009///
CY  - Cairo : 
PB  - Nermine Shawki Kamal , 
KW  - Bone markers
KW  - Metastatic bone disease
KW  - N - telopeptides
N1  - Thesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Oncology (Clinical); Issued also as CD
N2  - The prospective analysis of urinary N - telopeptides collagen break down products type I (NTX) in patients with metastatic bone disease revealed a positive relation between NTX level and risk of Sketal related events (SREs). Normalization of NTX level at 3 months decreases the rate of serious types of SREs (pathological fractures and cord compression) . Zoledronic acid decreases the rate of one or more SREs by four times in patients with elevated NTX levels compared to no Zoledronic acid
UR  - http://172.23.153.220/th.pdf
ER  -